Clinical trial
Evaluation of the Effectiveness of Electroacupuncture at Xuanzhong (GB39) and Tongli (HT5) Acupoints in Patients With Post-Stroke Aphasia
NCT07684781 is registered in ClinicalTrials.gov with University of Medicine and Pharmacy at Ho Chi Minh City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effectiveness of Electroacupuncture at Xuanzhong (GB39) and Tongli (HT5) Acupoints in Patients With Post-Stroke Aphasia
- Lead sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- January 31, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-stroke aphasia, psa